Viewing Study NCT04512261


Ignite Creation Date: 2025-12-24 @ 11:46 AM
Ignite Modification Date: 2025-12-28 @ 2:23 PM
Study NCT ID: NCT04512261
Status: WITHDRAWN
Last Update Posted: 2022-07-01
First Post: 2020-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases
Sponsor: Reva Basho
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module